|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2150-2158.
Prepublished online as a Blood First Edition Paper on June 13, 2006; DOI 10.1182/blood-2006-04-017608.
 Previous Article | Next Article 
Submitted December 22, 2005
Accepted May 29, 2006
DOCK2 regulates chemokine-triggered lateral lymphocyte
motility but not transendothelial migration
Ziv Shulman, Ronit Pasvolsky, Eilon Woolf, Valentin Grabovsky, Sara W. Feigelson, Noam Erez, Yoshinori Fukui, and Ronen Alon*
Department of Immunology, Weizmann Institute of Science
Division of Immunogenetics, Department of Immunobiology and Neuroscience, Kyushu University
* Corresponding author; email: ronen.alon{at}weizmann.ac.il.
Rac GTPases are key regulators of leukocyte motility. In
lymphocytes, chemokine-mediated Rac activation depends on
the CDM adaptor DOCK2. The present studies addressed the
role of DOCK2 in chemokine-triggered lymphocyte adhesion
and motility. Rapid chemokine-triggered activation of
both
LFA-1 and VLA-4 integrins took place normally in DOCK2-/-
T lymphocytes under various shear flow conditions.
Consequently, DOCK2-/- T cells arrested normally on
TNF?-activated endothelial cells in response to integrin
stimulatory chemokine signals, and their resistance to
detachment was similar to that of wt T lymphocytes.
Nevertheless, DOCK2-/- T lymphocytes exhibited reduced
microvillar collapse and lamellipodium extension in
response to chemokine signals, ruling out a role for
these
events in integrin-mediated adhesion strengthening.
Strikingly, arrested DOCK2-/- lymphocytes transmigrated
through a CCL21 presenting endothelial barrier with
similar efficiency and rate as wt lymphocytes but, unlike
wt lymphocytes, could not locomote away from the
transmigration site of the basal endothelial side.
DOCK2-/- lymphocytes also failed to laterally migrate
over
multiple integrin ligands co-immobilized with chemokines.
This is a first indication that T lymphocytes use two
different chemokine-triggered actin remodeling programs:
the first, DOCK2 dependent, to locomote laterally along
apical and basal endothelial surfaces; the second, DOCK2
independent, to cross through a chemokine-bearing
endothelial barrier.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. J. Cimino, I. Sokal, J. Leverenz, Y. Fukui, and T. J. Montine
DOCK2 Is a Microglial Specific Regulator of Central Nervous System Innate Immunity Found in Normal and Alzheimer's Disease Brain
Am. J. Pathol.,
October 1, 2009;
175(4):
1622 - 1630.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Dong, X. Du, J. Ye, M. Han, T. Xu, Y. Zhuang, and W. Tao
A Cell-Intrinsic Role for Mst1 in Regulating Thymocyte Egress
J. Immunol.,
September 15, 2009;
183(6):
3865 - 3872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Gollmer, F. Asperti-Boursin, Y. Tanaka, K. Okkenhaug, B. Vanhaesebroeck, J. R. Peterson, Y. Fukui, E. Donnadieu, and J. V. Stein
CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway
Blood,
July 16, 2009;
114(3):
580 - 588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gerard, R. A. van der Kammen, H. Janssen, S. I. Ellenbroek, and J. G. Collard
The Rac activator Tiam1 controls efficient T-cell trafficking and route of transendothelial migration
Blood,
June 11, 2009;
113(24):
6138 - 6147.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Imai, E. J. Park, D. Peer, A. Peixoto, G. Cheng, U. H. von Andrian, C. V. Carman, and M. Shimaoka
Genetic perturbation of the putative cytoplasmic membrane-proximal salt bridge aberrantly activates {alpha}4 integrins
Blood,
December 15, 2008;
112(13):
5007 - 5015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. N. Hartmann, V. Grabovsky, R. Pasvolsky, Z. Shulman, E. C. Buss, A. Spiegel, A. Nagler, T. Lapidot, M. Thelen, and R. Alon
A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells
J. Leukoc. Biol.,
October 1, 2008;
84(4):
1130 - 1140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Gotoh, Y. Tanaka, A. Nishikimi, A. Inayoshi, M. Enjoji, R. Takayanagi, T. Sasazuki, and Y. Fukui
Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells
Blood,
March 15, 2008;
111(6):
2973 - 2976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Pasvolsky, S. W. Feigelson, S. S. Kilic, A. J. Simon, G. Tal-Lapidot, V. Grabovsky, J. R. Crittenden, N. Amariglio, M. Safran, A. M. Graybiel, et al.
A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets
J. Exp. Med.,
July 9, 2007;
204(7):
1571 - 1582.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nombela-Arrieta, T. R. Mempel, S. F. Soriano, I. Mazo, M. P. Wymann, E. Hirsch, C. Martinez-A., Y. Fukui, U. H. von Andrian, and J. V. Stein
A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress
J. Exp. Med.,
March 19, 2007;
204(3):
497 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gerard, A. E.E. Mertens, R. A. van der Kammen, and J. G. Collard
The Par polarity complex regulates Rap1- and chemokine-induced T cell polarization
J. Cell Biol.,
March 12, 2007;
176(6):
863 - 875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
